The Point of Care Revolution is Here
Plasmotica, is seed-funded in stealth mode, has developed a portable a prototype for sensitive analyte measurements with design specifications down to pico-molar level sensitivity, it comprises several detection technologies including fluorescence and electrochemical. The prototype instrument was designed to be able to detect samples as small as 1 ┬ÁL (1 micro-liter) and with demonstrated capabilities down to the pM (pico-Molar) level. The design was implemented and tested in collaboration with several world-class Contract Research and Development Organizations (CRDO), which positions the system as widely compatible with a variety of commercially available assays for clinically important biomarkers
Plasmotica's technology is patented.
Contact us
To contact us, please send an email to Dr. Ned Saleh. NS@plasmotica.com